Alternativas a Tresiba: costo vs. otras insulinas basales
Tresiba cuesta $490-540/mes, 2-4 veces más que la glargina biosimilar ($150). DEVOTE mostró 53% menos hipoglucemia nocturna severa que glargina.
Insulin Degludec
75 source-based articles maintained by the HealthRX.com Editorial Team.
75articles
6topic areas covered
May 26, 2026latest review
Insulin Degludec library
Showing 75 of 75 clinical reviews.
Does Aetna (CVS Health) Cover Tresiba (Insulin Degludec)?
A complete guide to Aetna (CVS Health) coverage of Tresiba (insulin degludec): formulary tier, prior authorization criteria, step therapy requirements, appeal strategy, and cost-saving options for type 1 and type 2 diabetes patients.
Does Anthem (Elevance Health) Cover Tresiba (Insulin Degludec)?
What is actually knowable about Anthem (Elevance Health) coverage of Tresiba: typical utilization management patterns, how to confirm your own plan's rules, appeal rights, and cost-reduction options while you wait.
Does Blue Cross Blue Shield (Federated) Cover Tresiba (Insulin Degludec)?
A detailed guide to Blue Cross Blue Shield (Federated) coverage for Tresiba (insulin degludec), including formulary tiers, prior authorization criteria, step therapy requirements, and how to appeal a denial.
Does Medicare Advantage Cover Tresiba (Insulin Degludec)?
A clinical guide to Medicare Advantage coverage of Tresiba (insulin degludec), including formulary tiers, prior authorization criteria, step therapy requirements, appeal strategies, and cost-saving options for 2024-2025.
Does Tresiba Need to Be Refrigerated? Storage and 56-Day Guide
Tresiba storage: keep unopened pens refrigerated at 36-46°F until the printed expiry; once opened or at room temperature below 86°F, discard after 56 days.
Does TRICARE Cover Tresiba? Formulary Tier, Prior Authorization, and Appeal Steps
TRICARE covers Tresiba (insulin degludec) for type 1 and type 2 diabetes with prior authorization. Learn the formulary tier, step therapy rules, PA criteria, appeal process, and cost-saving options for military beneficiaries.
Does UnitedHealthcare Cover Tresiba (Insulin Degludec)?
A clinical and coverage guide to UnitedHealthcare's formulary policies for Tresiba (insulin degludec), including prior authorization criteria, step therapy rules, appeal pathways, and cost-reduction options.
How to Get Tresiba (Insulin Degludec) in New York
A step-by-step guide to getting a Tresiba prescription in New York, covering telehealth visits, prior authorization, pharmacy options, and what labs you need before your first dose.
How to Get Tresiba in Arkansas: Telehealth, Prescriptions, and Pharmacy Access
A complete guide to obtaining insulin degludec (Tresiba) in Arkansas, covering telehealth prescribing, prior authorization, pharmacy options, and clinical evidence behind the drug.
How to Get Tresiba in Florida: Prescriptions, Telehealth, and Pharmacies
A complete guide to getting insulin degludec (Tresiba) in Florida, covering telehealth prescribing, prior authorization, 503A compounding pharmacies, and transfer rules, prepared by the HealthRX.com Editorial Team.
How to Get Tresiba in Idaho: Prescriptions, Telehealth, and Pharmacy Guide
A complete guide to getting insulin degludec (Tresiba) in Idaho, covering telehealth prescribing, prior authorization, pharmacy options, and clinical evidence.
How to Get Tresiba in Iowa: Prescriptions, Telehealth, and Pharmacies
A complete guide to accessing insulin degludec (Tresiba) in Iowa, including telehealth prescribing, prior authorization, pharmacy options, and what labs you need before starting.
How to Get Tresiba in Louisiana
A complete guide to obtaining insulin degludec (Tresiba) in Louisiana, covering telehealth prescribing, pharmacy options, prior authorization, and the clinical evidence behind the medication.
How to Get Tresiba in Minnesota: Prescriptions, Telehealth, and Pharmacy Access
A complete clinical guide to obtaining insulin degludec (Tresiba) in Minnesota, covering telehealth prescribers, prior authorization, pharmacy options, and transfer rules.
How to Get Tresiba in New Jersey: Prescriptions, Telehealth, and Pharmacy Guide
A complete guide to obtaining insulin degludec (Tresiba) in New Jersey, covering telehealth prescribing, prior authorization, lab requirements, pharmacy options, and NJ Medicaid coverage.
How to Get Tresiba in Utah: Prescriptions, Telehealth, and Pharmacy Access
A complete guide to obtaining insulin degludec (Tresiba) in Utah, covering telehealth prescribing, pharmacy options, prior authorization, and clinical dosing backed by trial data.
How to Safely Stop Tresiba (Insulin Degludec): A Clinical Discontinuation Protocol
What is known and not yet established about discontinuing Tresiba (insulin degludec) safely, including taper principles, monitoring checkpoints, and when specialist input is required. Educational content pending qualified clinical review.
Switching From or To Tresiba (Insulin Degludec): Evidence-Based Protocols
Clinical protocols for switching between Tresiba (insulin degludec) and other basal insulins, including glargine U-100, glargine U-300, and detemir, with dose-conversion guidance and monitoring checkpoints.
Tresiba (Insulin Degludec) Adolescent Dosing: Ages 12 to 17
Evidence-based guide to insulin degludec (Tresiba) dosing in adolescents aged 12 to 17, covering initiation, titration, flexible timing, and safety data from the BEGIN YOUNG 1 trial.
Tresiba (Insulin Degludec) Dosing for Older Adults Ages 50 to 64
Complete clinical guide to insulin degludec (Tresiba) dosing for older adults aged 50 to 64, covering starting doses, titration schedules, hypoglycemia risk, cardiovascular evidence from DEVOTE, and polypharmacy considerations.
Tresiba (Insulin Degludec) Food & Supplement Interactions: What to Know
A guide to insulin degludec (Tresiba) food and supplement interactions, including alcohol, chromium, magnesium, and common supplements that affect blood glucose.
Tresiba (Insulin Degludec) for Metabolic Syndrome
Evidence-based guide to using Tresiba (insulin degludec) for metabolic syndrome, including off-label rationale, DEVOTE trial data, dosing, side effects, and insurance coverage.
Tresiba (Insulin Degludec) for NAFLD / MASLD: Evidence, Dosing, and Clinical Considerations
A comprehensive guide to using insulin degludec (Tresiba) in patients with NAFLD or MASLD, covering trial evidence, dosing, liver safety, and how it compares to other therapies.
Tresiba (Insulin Degludec) in Special Populations: Transplant, HIV, and Beyond
MD-level guide to insulin degludec (Tresiba) dosing, pharmacology, and clinical evidence in transplant recipients, people living with HIV, renal/hepatic impairment, older adults, and pregnancy. Cited to DEVOTE, FDA labeling, and primary PubMed sources.
Tresiba (Insulin Degludec) Monitoring for Adults 30, 49: Lab Schedules, Targets, and Practical Guidance
Evidence-based monitoring protocols for adults aged 30, 49 using Tresiba (insulin degludec), including HbA1c targets, CGM guidance, hypoglycemia tracking, and comorbidity screening schedules.
Tresiba (Insulin Degludec) Monitoring for Older Adults (50 to 64)
Evidence-based monitoring protocol for insulin degludec (Tresiba) in adults aged 50 to 64, covering HbA1c targets, hypoglycemia screening, cardiovascular checkpoints, and polypharmacy considerations.
Tresiba (Insulin Degludec) Monitoring for Young Adults (18 to 29)
What monitoring actually needs to look like for young adults aged 18 to 29 using Tresiba (insulin degludec): HbA1c targets, CGM use, hypoglycemia surveillance, and where the evidence for this specific age group is thin.
Tresiba (Insulin Degludec) Safety for Adults Ages 30 to 49
A guide to insulin degludec (Tresiba) safety in adults aged 30 to 49, covering hypoglycemia risk, cardiovascular data from DEVOTE, injection-site reactions, drug interactions, and practical dosing guidance.
Tresiba (Insulin Degludec) Safety in Adults 65 and Older
Evidence-based review of insulin degludec (Tresiba) safety in geriatric patients aged 65+, covering hypoglycemia risk, renal dosing, falls, and deprescribing guidance.
Tresiba (Insulin Degludec) Safety in Older Adults Aged 50, 64
Evidence-based safety profile of insulin degludec (Tresiba) for adults aged 50-64, covering hypoglycemia risk, cardiovascular outcomes from DEVOTE, polypharmacy considerations, and dosing guidance.
Tresiba (Insulin Degludec) Safety in Young Adults Aged 18 to 29
Evidence-based safety profile of insulin degludec (Tresiba) for young adults aged 18 to 29, covering hypoglycemia risk, cardiovascular outcomes, fertility considerations, and practical dosing guidance.
Tresiba Complete Drug-Drug Interaction Profile
An evidence-based guide to every clinically significant drug-drug interaction with insulin degludec (Tresiba), including mechanisms, severity levels, and management strategies.
Tresiba Cost in California 2026: Insulin Degludec Pricing, Coverage, and Savings Options
What you will pay for Tresiba (insulin degludec) in California in 2026, including Medi-Cal coverage rules, Novo Nordisk savings card terms, 503A compounding legality, and telehealth access.
Tresiba Cost in District of Columbia 2026
A complete guide to insulin degludec (Tresiba) pricing, Medicaid coverage, insurance options, and discount programs in the District of Columbia in 2026.
Tresiba Cost in Florida: Insulin Degludec Prices, Insurance, and Savings
A guide to understanding insulin degludec (Tresiba) costs in Florida: how list price differs from what patients actually pay, how Florida Medicaid and commercial insurance typically handle it, and what to verify before relying on any specific dollar figure.
Tresiba Cost in Georgia 2026: Prices, Medicaid, Insurance, and Legal Alternatives
Find out exactly what Tresiba (insulin degludec) costs in Georgia in 2026, whether Georgia Medicaid covers it, how compounded insulin degludec works legally, and which savings programs bring the cash price to $35 per month.
Tresiba Cost in Hawaii 2026: Insulin Degludec Prices, Coverage, and Savings Options
Find out exactly what Tresiba (insulin degludec) costs in Hawaii in 2026, which insurance and Medicaid plans cover it, whether compounded versions are legal, and the fastest ways to reduce your out-of-pocket expense.
Tresiba Cost in Idaho 2026: Cash Price, Medicaid, Insurance, and Compounded Options
Complete 2026 guide to insulin degludec (Tresiba) cost in Idaho. Covers cash price, Idaho Medicaid coverage status, insurance formularies, the Novo Nordisk savings card, and compounded insulin degludec via 503A pharmacies.
Tresiba Cost in Louisiana 2026: Cash Price, Medicaid, and Savings Options
Tresiba (insulin degludec) costs as little as $35/month cash-pay in Louisiana in 2026. Louisiana Medicaid does not cover it. Learn your savings options, telehealth access, and compounding legality.
Tresiba Cost in Maryland 2026: Prices, Coverage, and Savings Options
Tresiba (insulin degludec) costs $510/month list price in Maryland but most patients pay $35/month or less. Learn how Maryland Medicaid, insurance, manufacturer savings cards, and compounded insulin degludec can cut your out-of-pocket cost.
Tresiba Cost in Massachusetts 2026: Cash Price, Medicaid, and Insurance Guide
Find out exactly what insulin degludec (Tresiba) costs in Massachusetts in 2026, including cash prices, MassHealth Medicaid coverage rules, insurance prior authorization steps, and legal 503A compounding options.
Tresiba Cost in Michigan 2026: Prices, Insurance, Medicaid, and Savings Options
Find out exactly what insulin degludec (Tresiba) costs in Michigan in 2026, how Michigan Medicaid covers it, which insurance plans include it, and how to cut your monthly cost to as little as $35.
Tresiba Cost in Mississippi 2026: Insulin Degludec Prices, Medicaid Coverage, and Savings Options
Up-to-date guide to Tresiba (insulin degludec) costs in Mississippi for 2026, including Medicaid coverage rules, compounded insulin options, telehealth prescribing, and manufacturer savings programs.
Tresiba Cost in Montana 2026: What You'll Actually Pay
Insulin degludec (Tresiba) in Montana costs $35/month cash-pay at retail pharmacies in 2026, far below the $510 list price. Montana Medicaid does not cover it. Learn every savings route, from manufacturer cards to compounded degludec.
Tresiba Cost in Nevada 2026: Insulin Degludec Prices, Coverage, and Savings
Up-to-date 2026 cash prices, Nevada Medicaid status, insurance coverage, compounding legality, and savings programs for Tresiba (insulin degludec) in Nevada.
Tresiba Cost in New York 2026: Cash Price, Medicaid, Insurance, and Savings
What you will actually pay for insulin degludec (Tresiba) in New York in 2026, including Medicaid coverage rules, insurance prior authorization, the Novo Nordisk savings card, and whether compounded insulin degludec is legal in the state.
Tresiba Cost in North Carolina 2026: Prices, Insurance, Medicaid, and Savings Options
How much does Tresiba (insulin degludec) cost in North Carolina in 2026? Cash prices, Medicaid coverage rules, 503A compounding legality, insurance tiers, and the Novo Nordisk savings card explained with guidance.
Tresiba Cost in Oklahoma 2026: Cash Price, Medicaid, Insurance, and Compounded Options
Current Tresiba (insulin degludec) prices in Oklahoma for 2026, including cash-pay rates, Medicaid coverage status, insurance formulary tips, compounded insulin degludec legality, and manufacturer savings programs.
Tresiba Cost in South Carolina 2026: Prices, Medicaid, Insurance, and Compounding Options
Find out exactly what Tresiba (insulin degludec) costs in South Carolina in 2026, which insurance and Medicaid plans cover it, whether compounded insulin degludec is legal, and how to reduce your out-of-pocket cost to as little as $35/month.
Tresiba Cost in Tennessee 2026: Cash Price, Medicaid, and Insurance Guide
A complete 2026 guide to insulin degludec (Tresiba) cost in Tennessee, covering cash prices, TennCare Medicaid coverage, insurance tiers, compounded options, and savings programs.
Tresiba Cost in Texas 2026: Insulin Degludec Prices, Coverage, and Savings
How much does Tresiba (insulin degludec) cost in Texas in 2026? Cash prices, Texas Medicaid coverage, insurance options, manufacturer savings cards, and 503A compounding legality explained with clinical context.
Tresiba Cost in Virginia 2026: Price, Insurance, Medicaid, and Compounding Options
Exact 2026 prices for insulin degludec (Tresiba) in Virginia, including Medicaid PA requirements, Novo Nordisk savings programs, 503A compounding rules, and telehealth access.
Tresiba Cost in Wyoming 2026: Insulin Degludec Prices, Coverage, and Savings
A guide to Tresiba (insulin degludec) costs in Wyoming in 2026, including Medicaid coverage, insurance options, compounding legality, and manufacturer savings programs.
Tresiba Dosing for Adults 30-49: Units and Titration Steps
For adults 30-49, Tresiba starts at 10 units daily for insulin-naive type 2 diabetes, or 80% of prior basal dose when converting, adjusted per fasting glucose.
Tresiba Dosing in Hepatic Impairment: A Clinician's Guide to Insulin Degludec
Evidence-based guidance on insulin degludec (Tresiba) dosing, monitoring, and mechanism of action in patients with hepatic impairment, with citations to FDA labeling, PubMed trials, and ADA standards.
Tresiba Dosing in Renal Impairment: What the Evidence Actually Shows
Evidence-based guide to insulin degludec (Tresiba) dosing in patients with renal impairment, including CKD stages 3-5 and dialysis. Covers pharmacokinetics, dose adjustments, hypoglycemia risk, and monitoring protocols.
Tresiba Duration of Action: 42+ Hours Explained
Tresiba (insulin degludec) lasts over 42 hours at steady state, with a 25-hour half-life, thanks to stable multi-hexamer depots releasing insulin slowly.
Tresiba for Type 2 Diabetes: Evidence, Dosing, and Clinical Use
A guide to insulin degludec (Tresiba) for type 2 diabetes, covering trial evidence from DEVOTE, dosing protocols, hypoglycemia risk, and how it compares to insulin glargine.
Tresiba Future Formulations & Pipeline: What's Next for Insulin Degludec
A clinician-level review of insulin degludec (Tresiba) mechanism, current clinical evidence, and the full development pipeline including IDegAsp, IDegLira, ultra-concentrated variants, and oral delivery research.
Showing the first 60 matches. Use search or filters to narrow the library.